Acute myeloid leukemia patients trang 1 tải miễn phí từ TAILIEUCHUNG

"Acute myeloid leukemia patients" trang 1 - tải miễn phí từ Tailieuchung

Frequency and prognostic significant of CYP3A4- A-290G polymorphism in acute myeloid leukemia

Frequency and prognostic significant of CYP3A4- A-290G polymorphism in acute myeloid leukemia

5 58 0

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies

9 20 1

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

14 62 0

A study on effectiveness of leukepheresis in patients with hyperleukocytic leukemias

A study on effectiveness of leukepheresis in patients with hyperleukocytic leukemias

7 23 1

Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia

Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia

6 67 0

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

12 84 0

DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

8 48 1

Establishment of a diagnostic procedure and preliminary scanning for length mutations in cebpa/bzip domain in Vietnamese acute myeloid leukemia patients

Establishment of a diagnostic procedure and preliminary scanning for length mutations in cebpa/bzip domain in Vietnamese acute myeloid leukemia patients

6 35 0

Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital

Long-term outcome of childhood acute myeloid leukemia at Hue Central Hospital

6 81 0

Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients

Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients

11 40 0

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

8 67 0

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: A systematicreview and meta-analysis

11 80 0

Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients

Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients

8 26 1

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

11 46 3

Báo cáo y học: "Hypocellular acute myeloid leukemia with bone marrow necrosis in young patients: two case report"

4 25 0

báo cáo hóa học:

báo cáo hóa học:" High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia"

8 37 0

Báo cáo y học: "A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome"

36 62 0

báo cáo khoa học:

báo cáo khoa học: "A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China"

5 53 0

báo cáo khoa học:

báo cáo khoa học: "Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML)"

9 63 0

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis

9 44 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.